[Neomycin resorption from the normal and inflammatorily altered peritoneum].

Area of Science:

• Pharmacology and Toxicology
• Experimental Medicine

Background:

• Neomycin is an antibiotic with potential clinical applications.
• Understanding Neomycin's absorption from the peritoneal cavity is crucial for safe and effective therapeutic use.
• Inflammation can alter drug absorption dynamics.

Purpose of the Study:

• To investigate the resorption of Neomycin from normal and inflamed peritoneal cavities in guinea pigs.
• To determine the pharmacokinetics of Neomycin in serum and perilymph following different administration routes.

Main Methods:

• Experimental study involving 197 guinea pigs.
• Administration of Neomycin via subcutaneous injection and into the peritoneal cavity (normal and inflamed).
• Pharmacokinetic analysis of Neomycin concentrations in serum and perilymph.

Main Results:

• No statistically significant differences were observed in Neomycin pharmacokinetics between serum and perilymph across different experimental groups.
• Absorption patterns of Neomycin were consistent irrespective of peritoneal cavity status (normal vs. inflamed).

Conclusions:

• Neomycin resorption from the peritoneal cavity in guinea pigs appears consistent, even in the presence of inflammation.
• The findings suggest predictable Neomycin distribution to perilymph from the peritoneal cavity, with implications for clinical dosing and safety.